Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report-Reference-Cited by-同舟云学术

Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report

Published:2023-12-16 Issue: Volume: Page:
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Fujita Naoya^ORCID,Ono Yosuke,Hashimoto Kenichi,Kawamura Yusuke,Kimata Motohiro,Sekizawa Akinori,Obuchi Yasuhiro,Tanaka Yuji

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-023-06998-y.pdf

Reference16 articles.

1. Hildebrand GK, Kasi A (2022) Denosumab, in: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK535388/. Accessed on May 31, 2023

2. Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513–523. https://doi.org/10.1016/S2213-8587(17)30138-9

3. Nasser SM, Sahal A, Hamad A, Elazzazy S (2019) Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: a retrospective cohort study. J Oncol Pharm Pract 25:1846–1852. https://doi.org/10.1177/1078155218820927

4. Torres-Ortiz A, Acharya P, Cheungpasitporn W (2019) Successful treatment of tuberculosis-associated hypercalcemia with denosumab in a patient with acute kidney injury. Ther Apher Dial 23:484–485. https://doi.org/10.1111/1744-9987.12788

5. Abd Jalil AA, Wan Muhamad Hatta SF, Mohamad AF, Abdul Rani MF (2021) Denosumab as the treatment of recalcitrant tuberculous pleural effusion-associated hypercalcemia. Case Rep Med 2021:5544848. https://doi.org/10.1155/2021/5544848

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prednisone;Reactions Weekly;2024-06-08